Susan Dorsch

Last updated

Susan Evelyn Dorsch (born 25 March 1935) is an Australian physician and educator. She became the first female appointed to Professorship in the Faculty of Medicine at the University of Sydney. [1] She is Emeritus Professor at the University of Sydney. [2]

Life and career

Susan Dorsch was born on 25 March 1935 in Sydney, New South Wales, Australia. [3] In 1958, she graduated from medicine at the University of Sydney. [4] In 1958–1959, Dorsch was a Resident Medical Officer at the Royal Prince Alfred Hospital in Sydney. [5] Between 1959 and 1969, Dorsch worked as General Practitioner at Harden, New South Wales. [3] In 1970, she was appointed Teaching Fellow in the University of Sydney's Department of Pathology. [4] The same year Dorsch started her postgraduate research study at the University of Sydney that continued until 1974. [5] In 1974 she worked as a Senior Research Officer for the National Health and Medical Research Council (NHMRC) in the Department of Pathology becoming Senior Lecturer in 1975, Associate Professor in 1981 and Professor in 1983. [4]

Dorsch was the first female appointed to Professorship in the Faculty of Medicine at the University of Sydney. [1] Between 1978 and 1987 Dorsch supervised Bachelor and PhD students in the Faculty of Medicine as well as Master and PhD students in the Faculty of Science. [4]

From 1983 to 1986, she was a member of the Rhodes Scholarship Selection Committee, [3] from 1984 to 1987 – a member of the Harkness Fellowship Selection Committee. [5]

In 1985, Dorsch chaired the committee on the Centenary of the First Women Graduates. [4] In 1986 she was appointed Pro-Vice-Chancellor of the University of Sydney and in 1989 Deputy Vice-Chancellor, remaining on the position until 1995. [4] Between 1989 and 1996, Dorsch was a Director of the Northern Area Health Service Board. [3] From 1991 to 1993 Dorsch was a Member of the National Health and Medical Research Council (NHMRC). [5] In 1991–1994, she was also a Chairman of the Australian American Education Foundation. [3]

Since 1995, Dorsch is Emeritus Professor of the Faculty of Medicine at the University of Sydney. [2] In 1996, she received the honorary degree of Doctor of the University of Sydney. [4]

Related Research Articles

Peter Baume

Peter Erne Baume, AC is a retired Australian doctor and politician. He was a Senator for New South Wales from 1974 to 1991, representing the Liberal Party. He served as Minister for Aboriginal Affairs (1980–1982) and Minister for Education (1982–1983) in the Fraser Government.

Sue Desmond-Hellmann American academic administrator

Sue Desmond-Hellmann is an American oncologist and biotechnology leader who served as the Chief Executive Officer of the Bill & Melinda Gates Foundation from 2014–2020. She was previously Chancellor of the University of California, San Francisco (UCSF), the first woman to hold the position, and Arthur and Toni Rembe Rock Distinguished Professor, and before that president of product development at Genentech, where she played a role in the development of the first gene-targeted cancer drugs, Avastin and Herceptin.

Christopher Carl Goodnow is an immunology researcher and the current Executive Director of the Garvan Institute of Medical Research. He holds the Bill and Patricia Ritchie Foundation Chair and is a Conjoint Professor in the Faculty of Medicine at UNSW Sydney. He holds dual Australian and US citizenship.

Sir Edward Byrne is a neuroscientist who served as Principal of King's College London from August 2014 until January 2021.

Nicholas "Nick" Talley FRACP, FAFPHM, FRCP (Lond), FRCP (Edin), FACP, FACG, AGAF, FAHMS is an Australian gastroenterologist, epidemiologist, researcher, and clinical educator.

Brendan Crabb Australian scientist (born 1966)

Brendan Scott Crabb PhD FAHMS FASM is an Australian microbiologist, research scientist and Director and Chief Executive Officer of the Burnet Institute, based in Melbourne, Victoria, Australia.

Josephine Forbes Australian scientist

Josephine Forbes is an Australian scientist specialising in the study of glycation and diabetes. She has been studying diabetes since 1999 and has worked at Royal Children's Hospital, University of Melbourne and Baker Heart and Diabetes Institute in Melbourne Australia. Since 2012 she has led the Glycation and Diabetes team at Mater Research which is a world-class medical research institute based at South Brisbane, and part of the Mater Group. Josephine is program leader for Mater's Chronic Disease Biology and Care theme, building greater understanding of the biological basis of a broad range of chronic diseases, and developing preventative strategies and innovative treatments to improve patient outcomes. Josephine and her team focus on how advanced glycation contributes to the pathogenesis of diabetes and its complications such as kidney disease.

Rosetta Martiniello-Wilks is an Australian cancer researcher and the current president of the Australasian Gene and Cell Therapy Society. She is a senior lecturer in the School of Medical and Molecular Biosciences at the University of Technology Sydney (UTS) in Ultimo, Sydney, Australia. Martiniello-Wilks is a core member of the Centre for Health Technologies at UTS and head of the Translational Cancer Research Group in the School of Medical and Molecular Biosciences, Faculty of Science, UTS.

Jennifer Stow Australian scientist

Jennifer Lea Stow is deputy director (research), NHMRC Principal Research Fellow and head of the Protein Trafficking and Inflammation laboratory at the Institute for Molecular Bioscience (IMB), The University of Queensland, Australia. She was awarded her PhD from Monash University in Melbourne in 1982. As a Fogarty International Fellow, she completed postdoctoral training at Yale University School of Medicine (US) in the Department of Cell Biology. She was then appointed to her first faculty position as an assistant professor at Harvard University in the Renal Unit, Departments of Medicine and Pathology at the Massachusetts General Hospital in Boston. At the end of 1994 she returned to Australia as a Wellcome Trust Senior International Medical Research fellow at The University of Queensland where her work has continued. Stow sits on national and international peer review and scientific committees and advisory boards. She has served as head of IMB's Division of Molecular Cell Biology, and in 2008 she was appointed as deputy director (research).

Stephen Leeder is an emeritus professor of public health and community medicine at the University of Sydney, where he was dean of medicine from 1997 to 2002. Leeder is an adjunct professor of public health at the Western Sydney University, an adjunct professor of epidemiology at the Columbia University Mailman School of Public Health in New York and chair of the Western Sydney Local Health District Board.

Leslie Lazarus

Leslie "Les" Lazarus AO is an Australian endocrinologist who was one of the first co-Directors of the Garvan Institute of Medical Research, Sydney from 1966 to 1969 and sole Director from 1969 to 1990. At the Garvan Institute he led a joint laboratory and clinical research team studying diabetes and pituitary hormone secretions, in particular the secretion and clinical uses of human growth hormone.

Beryl Nashar Australian geologist

Beryl Scott Nashar was an Australian geologist, academic and first female Dean at an Australian university.

John Dwyer (medicine) Australian doctor, professor of medicine, and public health advocate (born 1939).

John Michael Dwyer, is an Australian doctor, professor of medicine, and public health advocate. He was originally a Professor of Medicine and Paediatrics, then Head of the Department of Clinical Immunology at Yale University. Returning to Australia, he became Head of the Department of Medicine and the Clinical Dean at the University of New South Wales and Director of Medicine at Sydney's Prince of Wales Hospital, the University's major teaching hospital, for over twenty years. In retirement he is an Emeritus Professor of Medicine of the University. He founded the Australian Health Care Reform Alliance, and was the founding president of the Friends of Science in Medicine until 2019. He was appointed an Officer of the Order of Australia for his service to public health.

Lieutenant-Colonel Charles Ruthven Bickerton Blackburn was a professor of medicine at the University of Sydney.

Melissa Little Australian scientist and academic (born 1963)

Professor Melissa Little is an Australian scientist and academic, currently Theme Director of Cell Biology, heading up the Kidney Regeneration laboratory at the Murdoch Children's Research Institute. She is also a Professor in the Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, and Program Leader of Stem Cells Australia.

David Joshua Handelsman, (AO) is trained in Medicine and Endocrinology. His expertise is in testicular function and androgen physiology, pharmacology, and toxicology. His experience spans basic, clinical, and public health domains including a recent focus on genetic models of androgen action, steroid mass spectrometry, and anti-doping science. He was Australia’s first Professor in Reproductive Endocrinology and Andrology. He has worked in the USA, Australia, and Germany. His professional involvement includes the World Health Organisation (WHO) Human Reproduction Programme's Male Task Force, WHO Human Reproduction Programme, United Nations Fund for Population Activities, Endocrine Society of Australia, World Anti-Doping Agency’s Health, Medicine and Research Committee, and Australian Drug Evaluation Committee.

Janice Clare Reid is an Australian academic and medical anthropologist, who has specialised in Aboriginal and refugee health. She was Vice-Chancellor of the University of Western Sydney from 1998 to 2013.

Susan Margaret Pond is an Australian scientist and technologist active in business and academia, and is recognised for her contributions to medicine, biotechnology, renewable energy and sustainability. She was the first woman to be appointed to a Personal Professorial Chair in the Department of Medicine at the University of Queensland, the first woman to receive the Wellcome Australia Medal, and the first female Managing Director of a Johnson & Johnson Company in Australia. She is currently Chair of the NSW Smart Sensing Network (NSSN). From February 2017 to May 2018 she was the Director of Sydney Nano.

Professor Susan J. Clark is an Australian biomedical researcher in epigenetics of development and cancer. She was elected a Fellow of the Australian Academy of Science in 2015, and is a National Health and Medical Research Council (NHMRC) Senior Principal Research Fellow and Research Director and Head of Genomics and Epigenetics Division at the Garvan Institute of Medical Research. Clark developed the first method for bisulphite sequencing for DNA methylation analysis and used it to establish that the methylation machinery of mammalian cells is capable of both maintenance and de novo methylation at CpNpG sites and showed is inheritable. Clark's research has advanced understanding of the role of DNA methylation, non-coding RNA and microRNA in embryogenesis, reprogramming, stem cell development and cancer and has led to the identification of epigenomic biomarkers in cancer. Clark is a founding member of the International Human Epigenome Consortium (IHEC) and President of the Australian Epigenetics Alliance (AEpiA).

References

  1. 1 2 "Tissue Pathology at RPA". www.tissuepathologyatrpa.com.au. Retrieved 2020-10-14.
  2. 1 2 "Dorsch, Susan Evelyn". trove.nla.gov.au. Retrieved 2020-10-14.
  3. 1 2 3 4 5 Centre, The University of Melbourne eScholarship Research. "Dorsch, Susan Evelyn - Biographical entry - Encyclopedia of Australian Science". www.eoas.info. Retrieved 2020-10-14.
  4. 1 2 3 4 5 6 7 "Dorsch, Susan Evelyn - Faculty of Medicine Online Museum and Archive". www.sydney.edu.au. Retrieved 2020-10-14.
  5. 1 2 3 4 Centre, The University of Melbourne eScholarship Research. "Dorsch, Susan Evelyn - Bright Sparcs Biographical entry". www.asap.unimelb.edu.au. Retrieved 2020-10-14.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.